CLASS II Device recall · Reported 6 Apr 2022 · FDA Enforcement Report

CARA (Computer Assisted Retinal Analysis), Product ID recalled

Diagnos is recalling CARA (Computer Assisted Retinal Analysis), Product ID: +B543CARA0/$$+7V4.7.2/16D202111179, distributed in California. The recall was initiated on 11 Jan 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSoftware Version 4.7.2
Quantity recalled1

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0826-2022
FDA event ID
89715
Recalling firm
Diagnos, Brossard, N/A
Classification
Class II
Status
Terminated
Recall initiated
11 Jan 2022
FDA classified
25 Mar 2022
Reported
6 Apr 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

11 Jan 2022Recall initiated by company
25 Mar 2022Classified by FDA+73 days
6 Apr 2022Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Retinal analysis system software has some features, based on artificial intelligence, that potentially lack appropriate market approval, so it is recommended to use a specific prior software version.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

CARA (Computer Assisted Retinal Analysis), Product ID: +B543CARA0/$$+7V4.7.2/16D202111179

Where it was distributed

US: CA

California

Questions about this recall

Is CARA (Computer Assisted Retinal Analysis), Product ID: +B543CARA0/$$+7V4.7.2/16D202111179 recalled?

Yes. Diagnos recalled CARA (Computer Assisted Retinal Analysis), Product ID: +B543CARA0/$$+7V4.7.2/16D202111179 on 11 Jan 2022. The recall is Class II and its status is Terminated. Recall number Z-0826-2022.

Why was it recalled?

Retinal analysis system software has some features, based on artificial intelligence, that potentially lack appropriate market approval, so it is recommended to use a specific prior software version.

Which lots are affected?

Software Version 4.7.2

Where was it sold?

US: CA

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Other Medical Devices recalls

All 13,778